Clinical Trials Directory

Trials / Completed

CompletedNCT06167395

Study to Analyze the Aerobic Performance Efficacy of Chronic Intake With a β-alanine Supplement in Recreational Cyclists

Randomized Clinical Trial to Analyze the Efficacy of Chronic Intake of Different Doses of a β-alanine Supplement on Aerobic Performance in Recreational Long-Distance Road Cyclists

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
75 (actual)
Sponsor
Universidad Católica San Antonio de Murcia · Academic / Other
Sex
Male
Age
18 Years – 60 Years
Healthy volunteers
Accepted

Summary

Randomized, controlled, double-blind, double-blind clinical trial, with three parallel arms depending on the product consumed (experimental product dose 1 and dose 2 and placebo product) and single-center, to measure the efficacy of a sustained release beta alanine on the aerobic performance efficacy in recreational cyclist

Detailed description

Subjects meeting the selection criteria will be randomly assigned to each of the study groups (investigational product dose 1 or dose 2, or placebo, depending on the group to which they have been assigned). The product to be consumed is beta alanine. Participants will consume the product for 30 days. They will have to take 4 intakes every three hours, being the first intake two hours after waking up. The study subjects will have to make 2 visits to the laboratory. At the first and last visit, their aerobic performance will be evaluated by an incremental test to exhaustion with gas analysis.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTBeta Alanine high doseSubjects should consume 4 intakes of 5 g of beta alanine every 3 hours each day.
DIETARY_SUPPLEMENTBeta Alanine low doseSubjects should consume 4 intakes of 2,5 g of beta alanine every 3 hours each day.
DIETARY_SUPPLEMENTControl productSubjects should consume 4 intakes of 2,5 g of wheat semolina every 3 hours each day.

Timeline

Start date
2023-12-04
Primary completion
2024-02-19
Completion
2024-03-29
First posted
2023-12-12
Last updated
2024-05-17

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT06167395. Inclusion in this directory is not an endorsement.